Medicus Pharma Ltd. MDCX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.57M | 5.89M | 5.20M | 5.02M | 4.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.48M | 8.60M | 7.79M | 6.71M | 6.02M |
| Operating Income | -11.48M | -8.60M | -7.79M | -6.71M | -6.02M |
| Income Before Tax | -11.68M | -9.04M | -15.07M | -20.94M | -6.18M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.68M | -9.04M | -15.07M | -20.94M | -6.18M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 66.70K | 200.00 | 100.00 | 100.00 | -- |
| Net Income | -11.62M | -9.04M | -15.07M | -20.94M | -6.18M |
| EBIT | -11.48M | -8.60M | -7.79M | -6.71M | -6.02M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -10.55 | -15.30 | -40.50 | -56.18 | -21.62 |
| Normalized Basic EPS | -6.57 | -9.43 | -25.11 | -19.54 | -13.07 |
| EPS Diluted | -10.55 | -15.30 | -40.50 | -56.18 | -21.62 |
| Normalized Diluted EPS | -6.57 | -9.43 | -25.11 | -19.54 | -13.07 |
| Average Basic Shares Outstanding | 1.10M | 590.80K | 372.00K | 372.60K | 285.70K |
| Average Diluted Shares Outstanding | 1.10M | 590.80K | 372.00K | 372.60K | 285.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |